Finding useful biomarkers for Parkinson’s disease

Authors: Alice Chen‐Plotkin, Roger L. Albin, Roy N. Alcalay, Debra Babcock, Vikram S. Bajaj, Dubois Bowman, Alex Buko, Jesse M. Cedarbaum, Daniel Chelsky, Mark Cookson, Ted M. Dawson, Richard B. Dewey, Tatiana Foroud, Mark Frasier, Dwight C. German, Katrina Gwinn, Xuemei Huang, Catherine Kopil, Thomas Kremer, Shirley Lasch, Kenneth Marek, Jarrod A. Marto, Kalpana Merchant, Brit Mollenhauer, Anna Naito, Judith A. Potashkin, Alyssa Reimer, Liana S. Rosenthal, Rachel Saunders‐Pullman, Clemens R. Scherzer, Todd Sherer, Andrew Singleton, Margaret Sutherland, Ines Thiele, Marcel van der Brug, Kendall Van Keuren‐Jensen, David E. Vaillancourt, David R. Walt, Andrew B. West, Jing Zhang - Science Translational Medicine 2018 cited by 151

The recent advent of an "ecosystem" of shared biofluid sample biorepositories and data sets will focus biomarker efforts in Parkinson's disease, boosting the therapeutic development pipeline and enabling translation with real-world impact.